Stock PKBO PEAK BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Peak Bio, Inc.

Equities

PKBO

US70470P1084

Market Closed - OTC Markets
Other stock markets
 10:39:07 2024-06-25 EDT 		5-day change 1st Jan Change
0.0096 USD +11.63% Intraday chart for Peak Bio, Inc. -.--% -94.88%
06-25 Peak Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
05-28 Peak Bio, Inc. announced that it has received $1.3245 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Peak Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders
AQ
Peak Bio, Inc. announced that it has received $1.3245 million in funding
CI
Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc..
CI
Peak Bio, Inc. announced that it has received $2.238 million in funding
CI
Peak Bio, Inc. Receives Loan in the Principal Amount of $750,000
CI
Peak Bio, Inc. announced that it has received $0.075 million in funding
CI
Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing
GL
Peak Bio, Inc. announced a financing transaction
CI
Peak Bio : Private Placement - Form 8-K
PU
Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing
GL
Peak Bio, Inc. Announces Up-listing to OTCQB Market
GL
Peak Bio, Inc. Announces Up-listing to OTCQB Market
AQ
Peak Bio, Inc. Appoints Michael Friedman to Board of Directors and Member of Audit Committee and Compensation Committee
CI
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors
GL
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors
AQ
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market
GL
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market
AQ
Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital
GL
Peak Bio, Inc. announced that it expects to receive $100 million in funding from White Lion Capital Llc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PKBO Stock
  4. News Peak Bio, Inc.